Form 4: Chemours Co Director Livingston Satterthwaite Acquires Deferred Stock Units

Director Livingston Satterthwaite acquired deferred stock units equivalent to 970.0664 shares of Chemours Co common stock on March 31, 2025.

Summary

• Livingston Satterthwaite, a director of Chemours Co, acquired deferred stock units on March 31, 2025.
• The transaction involved the acquisition of 970.0664 deferred stock units, each equivalent to one share of Chemours Co common stock.
• The price per unit was $13.53.
• Following the transaction, Satterthwaite directly owns 970.0664 deferred stock units.
• These units become payable upon the second calendar year following the director's termination of service.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of a director's acquisition of deferred stock units. It doesn't inherently indicate positive or negative performance.

Future Outlook

The deferred stock units become payable upon the second calendar year following the Reporting Person's termination of service as a director.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a director's acquisition of deferred stock units, aligning their interests with the long-term performance of the company.

Stakeholder Impact

• The acquisition of deferred stock units by a director can align their interests with those of shareholders, potentially encouraging decisions that benefit the company's long-term value.

Key Dates

Keywords

Chemours Co, Director, Deferred Stock Units, Beneficial Ownership, Form 4, Satterthwaite, Acquisition